• Two novel regenerative medicine platforms for the treatment of soft tissues and bone
  • International manufacturing capabilities Expansive distribution opportunities
  • Multiple commercialization opportunities – innovative product portfolio and pipeline
  • Tissue processing science and development expertise
  • Differentiated clinical outcomes

You may also be interested in